Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PegBeLiver: PEG-IFN Duration and Combination in HBeAg-Negative CHB
NCT01095835Phase 3Completed
- Sponsor
- Roche
- Start
- Feb 2005
- Primary completion
- Jan 2010
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB), sponsored by Roche. Started Feb 2005; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01095835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01095835.